Fig. 3From: Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseasesOvarian function follow-up. Data are presented as mean ± SEM. (A) FSH and (B) estradiol values at the following time points: at inclusion; at 6 months, 1 and 2 years of follow-up. *P < 0.05. FSH, follicle-stimulating hormone; GnRHa, gonadotropin-releasing hormone agonistBack to article page